Business Context and Reporting Period
Company: CALIX, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: October 29, 2014
Reporting Period: Third quarter ended September 27, 2014
Context: The filing serves to publicly disseminate a press release announcing financial results for the specified quarter. The detailed financial data is contained in the attached press release (Exhibit 99.1) and is incorporated by reference.
Key Financial Metrics
The provided Form 8-K text acts as a notification of the results but does not contain specific numerical data. The filing explicitly states that the description is qualified by reference to the attached press release. Consequently, the following metrics are not present in the source text:
- Revenue
- Profit (Net Income/Loss)
- Cash Flow
- Margins
- Debt and Liquidity
Note: The filing text does not provide a clear value for any specific financial metric.
Material Changes
The filing text does not detail specific material changes versus the prior comparable period. It only confirms that financial results for the third quarter ended September 27, 2014, were announced. Specific comparisons must be derived from the referenced press release (Exhibit 99.1).
Guidance, Outlook, and Risks
The Form 8-K text does not include management commentary, forward-looking guidance, specific risks, contingencies, or unusual items. It strictly references the press release for the announcement of results. The filing includes a standard disclaimer that the information is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated October 29, 2014) for actual revenue, profit, and cash flow figures.
- Verify year-over-year and quarter-over-quarter performance trends in the attached press release.
- Check for any forward-looking statements or guidance updates in the press release not captured in this summary.
- Confirm the exact quarter end date (September 27, 2014) when comparing to other fiscal periods.